🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The investigators developed a dual-target CAR-T targeting CD38 and CS1. Pre...
Status
Active Not Recruiting
Location
Second Hospital of Shandong University
Start Date
2024-04-30
Trial ID
NCT06574958
Treatments Being Tested
This is a single-center, open-label, single-arm study to evaluate the safet...
Status
Unknown
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2020-03-25
Trial ID
NCT04662099
Treatments Being Tested
This phase I trial studies the side effects and best dose of CS1-chimeric a...
Status
Suspended
Location
City of Hope Medical Center
Start Date
2019-04-23
Trial ID
NCT03710421
Treatments Being Tested
This phase I trial studies the side effects and how well CART-BCMA/CS1 work...
Status
Withdrawn
Location
Melanie Ayala Ceja
Start Date
2024-03-28
Trial ID
NCT05950113
This is a Phase I, FIH, open-label, dose escalation study evaluating Safety...
Status
Terminated
Location
UCSF Medical Center- Helen Diller Family Comprehensive Cancer Center
Start Date
2019-11-21
Trial ID
NCT04142619
Treatments Being Tested
According to the high expression of tumor cell-associated antigen CD138, in...
Status
Unknown
Location
Jinhong Jiang
Start Date
2018-11-15
Trial ID
NCT03778346
Treatments Being Tested
Despite recent therapeutic advances, multiple myeloma (MM) remains an incur...
Status
Recruiting
Location
Washington University School of Medicine
Start Date
2024-08-22
Trial ID
NCT06185751
Treatments Being Tested
This is a phase I, interventional, single arm, open label, treatment study ...
Status
Unknown
Location
Chengdu Military General Hospital
Start Date
2018-08-31
Trial ID
NCT04156269
Treatments Being Tested
This Phase I clinical trial is evaluating chimeric-antigen receptor (CAR) T...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2015-03
Trial ID
NCT02203825
Treatments Being Tested
Clinical trial for the safety and efficacy of CS1-targeted CAR-T Cells ther...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital，College of Medicine, Zhejiang University
Start Date
2020-12-31
Trial ID
NCT04541368
Treatments Being Tested